Overview
Hirofumi Kai practices in Kumamoto, Japan. Kai is rated as an Elite expert by MediFind in the treatment of Alport Syndrome. Their top areas of expertise are Alport Syndrome, Familial Transthyretin Amyloidosis, Cystic Fibrosis, and Interstitial Nephritis.
Their clinical research consists of co-authoring 96 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 21 articles in the study of Alport Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Alport Syndrome
- Advanced
- Cystic FibrosisKai isAdvanced. Learn about Cystic Fibrosis.
- Familial Transthyretin Amyloidosis
- Interstitial Nephritis
- Experienced
- Cardiac AmyloidosisKai isExperienced. Learn about Cardiac Amyloidosis.
- Cerebral HypoxiaKai isExperienced. Learn about Cerebral Hypoxia.
- Chronic Kidney DiseaseKai isExperienced. Learn about Chronic Kidney Disease.
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic NephropathyKai isExperienced. Learn about Diabetic Nephropathy.
- EmphysemaKai isExperienced. Learn about Emphysema.